Global Cell Therapy CDMO Services Supply, Demand and Key Producers, 2023-2029
The global Cell Therapy CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cell Therapy CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy CDMO Services total market, 2018-2029, (USD Million)
Global Cell Therapy CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Therapy CDMO Services total market, key domestic companies and share, (USD Million)
Global Cell Therapy CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Cell Therapy CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Therapy CDMO Services total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell Therapy CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Medicilon Biopharmaceutical Co., Ltd., Puxin Biomedicine, Porton Bio, Lonza, Catalent, Oxford BioMedica, and meta organisms, GenScript and Huakan Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy CDMO Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Therapy CDMO Services Market, By Region:
1. How big is the global Cell Therapy CDMO Services market?
2. What is the demand of the global Cell Therapy CDMO Services market?
3. What is the year over year growth of the global Cell Therapy CDMO Services market?
4. What is the total value of the global Cell Therapy CDMO Services market?
5. Who are the major players in the global Cell Therapy CDMO Services market?
6. What are the growth factors driving the market demand?
This report studies the global Cell Therapy CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy CDMO Services total market, 2018-2029, (USD Million)
Global Cell Therapy CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Therapy CDMO Services total market, key domestic companies and share, (USD Million)
Global Cell Therapy CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Cell Therapy CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Therapy CDMO Services total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell Therapy CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Medicilon Biopharmaceutical Co., Ltd., Puxin Biomedicine, Porton Bio, Lonza, Catalent, Oxford BioMedica, and meta organisms, GenScript and Huakan Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy CDMO Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Therapy CDMO Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cell Therapy CDMO
- Cell Therapy CRO
- Pharmaceutical Company
- Research Institute
- Shanghai Medicilon Biopharmaceutical Co., Ltd.
- Puxin Biomedicine
- Porton Bio
- Lonza
- Catalent
- Oxford BioMedica
- and meta organisms
- GenScript
- Huakan Biology
1. How big is the global Cell Therapy CDMO Services market?
2. What is the demand of the global Cell Therapy CDMO Services market?
3. What is the year over year growth of the global Cell Therapy CDMO Services market?
4. What is the total value of the global Cell Therapy CDMO Services market?
5. Who are the major players in the global Cell Therapy CDMO Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell Therapy CDMO Services Introduction
1.2 World Cell Therapy CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Therapy CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Therapy CDMO Services Market Size (2018-2029)
1.3.3 China Cell Therapy CDMO Services Market Size (2018-2029)
1.3.4 Europe Cell Therapy CDMO Services Market Size (2018-2029)
1.3.5 Japan Cell Therapy CDMO Services Market Size (2018-2029)
1.3.6 South Korea Cell Therapy CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Cell Therapy CDMO Services Market Size (2018-2029)
1.3.8 India Cell Therapy CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell Therapy CDMO Services Consumption Value (2018-2029)
2.2 World Cell Therapy CDMO Services Consumption Value by Region
2.2.1 World Cell Therapy CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Cell Therapy CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Therapy CDMO Services Consumption Value (2018-2029)
2.4 China Cell Therapy CDMO Services Consumption Value (2018-2029)
2.5 Europe Cell Therapy CDMO Services Consumption Value (2018-2029)
2.6 Japan Cell Therapy CDMO Services Consumption Value (2018-2029)
2.7 South Korea Cell Therapy CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Cell Therapy CDMO Services Consumption Value (2018-2029)
2.9 India Cell Therapy CDMO Services Consumption Value (2018-2029)
3 WORLD CELL THERAPY CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy CDMO Services in 2022
3.3 Cell Therapy CDMO Services Company Evaluation Quadrant
3.4 Cell Therapy CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy CDMO Services Market: Region Footprint
3.4.2 Cell Therapy CDMO Services Market: Company Product Type Footprint
3.4.3 Cell Therapy CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Therapy CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Therapy CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Cell Therapy CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Therapy CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Cell Therapy CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy CDMO
5.2.2 Cell Therapy CRO
5.3 Market Segment by Type
5.3.1 World Cell Therapy CDMO Services Market Size by Type (2018-2023)
5.3.2 World Cell Therapy CDMO Services Market Size by Type (2024-2029)
5.3.3 World Cell Therapy CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Therapy CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Research Institute
6.3 Market Segment by Application
6.3.1 World Cell Therapy CDMO Services Market Size by Application (2018-2023)
6.3.2 World Cell Therapy CDMO Services Market Size by Application (2024-2029)
6.3.3 World Cell Therapy CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Shanghai Medicilon Biopharmaceutical Co., Ltd.
7.1.1 Shanghai Medicilon Biopharmaceutical Co., Ltd. Details
7.1.2 Shanghai Medicilon Biopharmaceutical Co., Ltd. Major Business
7.1.3 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product and Services
7.1.4 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.1.6 Shanghai Medicilon Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.2 Puxin Biomedicine
7.2.1 Puxin Biomedicine Details
7.2.2 Puxin Biomedicine Major Business
7.2.3 Puxin Biomedicine Cell Therapy CDMO Services Product and Services
7.2.4 Puxin Biomedicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Puxin Biomedicine Recent Developments/Updates
7.2.6 Puxin Biomedicine Competitive Strengths & Weaknesses
7.3 Porton Bio
7.3.1 Porton Bio Details
7.3.2 Porton Bio Major Business
7.3.3 Porton Bio Cell Therapy CDMO Services Product and Services
7.3.4 Porton Bio Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Porton Bio Recent Developments/Updates
7.3.6 Porton Bio Competitive Strengths & Weaknesses
7.4 Lonza
7.4.1 Lonza Details
7.4.2 Lonza Major Business
7.4.3 Lonza Cell Therapy CDMO Services Product and Services
7.4.4 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lonza Recent Developments/Updates
7.4.6 Lonza Competitive Strengths & Weaknesses
7.5 Catalent
7.5.1 Catalent Details
7.5.2 Catalent Major Business
7.5.3 Catalent Cell Therapy CDMO Services Product and Services
7.5.4 Catalent Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Catalent Recent Developments/Updates
7.5.6 Catalent Competitive Strengths & Weaknesses
7.6 Oxford BioMedica
7.6.1 Oxford BioMedica Details
7.6.2 Oxford BioMedica Major Business
7.6.3 Oxford BioMedica Cell Therapy CDMO Services Product and Services
7.6.4 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Oxford BioMedica Recent Developments/Updates
7.6.6 Oxford BioMedica Competitive Strengths & Weaknesses
7.7 and meta organisms
7.7.1 and meta organisms Details
7.7.2 and meta organisms Major Business
7.7.3 and meta organisms Cell Therapy CDMO Services Product and Services
7.7.4 and meta organisms Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 and meta organisms Recent Developments/Updates
7.7.6 and meta organisms Competitive Strengths & Weaknesses
7.8 GenScript
7.8.1 GenScript Details
7.8.2 GenScript Major Business
7.8.3 GenScript Cell Therapy CDMO Services Product and Services
7.8.4 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 GenScript Recent Developments/Updates
7.8.6 GenScript Competitive Strengths & Weaknesses
7.9 Huakan Biology
7.9.1 Huakan Biology Details
7.9.2 Huakan Biology Major Business
7.9.3 Huakan Biology Cell Therapy CDMO Services Product and Services
7.9.4 Huakan Biology Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Huakan Biology Recent Developments/Updates
7.9.6 Huakan Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Therapy CDMO Services Industry Chain
8.2 Cell Therapy CDMO Services Upstream Analysis
8.3 Cell Therapy CDMO Services Midstream Analysis
8.4 Cell Therapy CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell Therapy CDMO Services Introduction
1.2 World Cell Therapy CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Therapy CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Therapy CDMO Services Market Size (2018-2029)
1.3.3 China Cell Therapy CDMO Services Market Size (2018-2029)
1.3.4 Europe Cell Therapy CDMO Services Market Size (2018-2029)
1.3.5 Japan Cell Therapy CDMO Services Market Size (2018-2029)
1.3.6 South Korea Cell Therapy CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Cell Therapy CDMO Services Market Size (2018-2029)
1.3.8 India Cell Therapy CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell Therapy CDMO Services Consumption Value (2018-2029)
2.2 World Cell Therapy CDMO Services Consumption Value by Region
2.2.1 World Cell Therapy CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Cell Therapy CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Therapy CDMO Services Consumption Value (2018-2029)
2.4 China Cell Therapy CDMO Services Consumption Value (2018-2029)
2.5 Europe Cell Therapy CDMO Services Consumption Value (2018-2029)
2.6 Japan Cell Therapy CDMO Services Consumption Value (2018-2029)
2.7 South Korea Cell Therapy CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Cell Therapy CDMO Services Consumption Value (2018-2029)
2.9 India Cell Therapy CDMO Services Consumption Value (2018-2029)
3 WORLD CELL THERAPY CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy CDMO Services in 2022
3.3 Cell Therapy CDMO Services Company Evaluation Quadrant
3.4 Cell Therapy CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy CDMO Services Market: Region Footprint
3.4.2 Cell Therapy CDMO Services Market: Company Product Type Footprint
3.4.3 Cell Therapy CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Therapy CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Therapy CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Cell Therapy CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Therapy CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Cell Therapy CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Therapy CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy CDMO
5.2.2 Cell Therapy CRO
5.3 Market Segment by Type
5.3.1 World Cell Therapy CDMO Services Market Size by Type (2018-2023)
5.3.2 World Cell Therapy CDMO Services Market Size by Type (2024-2029)
5.3.3 World Cell Therapy CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Therapy CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Research Institute
6.3 Market Segment by Application
6.3.1 World Cell Therapy CDMO Services Market Size by Application (2018-2023)
6.3.2 World Cell Therapy CDMO Services Market Size by Application (2024-2029)
6.3.3 World Cell Therapy CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Shanghai Medicilon Biopharmaceutical Co., Ltd.
7.1.1 Shanghai Medicilon Biopharmaceutical Co., Ltd. Details
7.1.2 Shanghai Medicilon Biopharmaceutical Co., Ltd. Major Business
7.1.3 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product and Services
7.1.4 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.1.6 Shanghai Medicilon Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.2 Puxin Biomedicine
7.2.1 Puxin Biomedicine Details
7.2.2 Puxin Biomedicine Major Business
7.2.3 Puxin Biomedicine Cell Therapy CDMO Services Product and Services
7.2.4 Puxin Biomedicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Puxin Biomedicine Recent Developments/Updates
7.2.6 Puxin Biomedicine Competitive Strengths & Weaknesses
7.3 Porton Bio
7.3.1 Porton Bio Details
7.3.2 Porton Bio Major Business
7.3.3 Porton Bio Cell Therapy CDMO Services Product and Services
7.3.4 Porton Bio Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Porton Bio Recent Developments/Updates
7.3.6 Porton Bio Competitive Strengths & Weaknesses
7.4 Lonza
7.4.1 Lonza Details
7.4.2 Lonza Major Business
7.4.3 Lonza Cell Therapy CDMO Services Product and Services
7.4.4 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lonza Recent Developments/Updates
7.4.6 Lonza Competitive Strengths & Weaknesses
7.5 Catalent
7.5.1 Catalent Details
7.5.2 Catalent Major Business
7.5.3 Catalent Cell Therapy CDMO Services Product and Services
7.5.4 Catalent Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Catalent Recent Developments/Updates
7.5.6 Catalent Competitive Strengths & Weaknesses
7.6 Oxford BioMedica
7.6.1 Oxford BioMedica Details
7.6.2 Oxford BioMedica Major Business
7.6.3 Oxford BioMedica Cell Therapy CDMO Services Product and Services
7.6.4 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Oxford BioMedica Recent Developments/Updates
7.6.6 Oxford BioMedica Competitive Strengths & Weaknesses
7.7 and meta organisms
7.7.1 and meta organisms Details
7.7.2 and meta organisms Major Business
7.7.3 and meta organisms Cell Therapy CDMO Services Product and Services
7.7.4 and meta organisms Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 and meta organisms Recent Developments/Updates
7.7.6 and meta organisms Competitive Strengths & Weaknesses
7.8 GenScript
7.8.1 GenScript Details
7.8.2 GenScript Major Business
7.8.3 GenScript Cell Therapy CDMO Services Product and Services
7.8.4 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 GenScript Recent Developments/Updates
7.8.6 GenScript Competitive Strengths & Weaknesses
7.9 Huakan Biology
7.9.1 Huakan Biology Details
7.9.2 Huakan Biology Major Business
7.9.3 Huakan Biology Cell Therapy CDMO Services Product and Services
7.9.4 Huakan Biology Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Huakan Biology Recent Developments/Updates
7.9.6 Huakan Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Therapy CDMO Services Industry Chain
8.2 Cell Therapy CDMO Services Upstream Analysis
8.3 Cell Therapy CDMO Services Midstream Analysis
8.4 Cell Therapy CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell Therapy CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Therapy CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Therapy CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Therapy CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Therapy CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy CDMO Services Players in 2022
Table 12. World Cell Therapy CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Therapy CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy CDMO Services Player
Table 15. Cell Therapy CDMO Services Market: Company Product Type Footprint
Table 16. Cell Therapy CDMO Services Market: Company Product Application Footprint
Table 17. Cell Therapy CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Therapy CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Cell Therapy CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 29. World Cell Therapy CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Therapy CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Therapy CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Therapy CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Therapy CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Therapy CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Shanghai Medicilon Biopharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 36. Shanghai Medicilon Biopharmaceutical Co., Ltd. Major Business
Table 37. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product and Services
Table 38. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 40. Shanghai Medicilon Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 41. Puxin Biomedicine Basic Information, Area Served and Competitors
Table 42. Puxin Biomedicine Major Business
Table 43. Puxin Biomedicine Cell Therapy CDMO Services Product and Services
Table 44. Puxin Biomedicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Puxin Biomedicine Recent Developments/Updates
Table 46. Puxin Biomedicine Competitive Strengths & Weaknesses
Table 47. Porton Bio Basic Information, Area Served and Competitors
Table 48. Porton Bio Major Business
Table 49. Porton Bio Cell Therapy CDMO Services Product and Services
Table 50. Porton Bio Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Porton Bio Recent Developments/Updates
Table 52. Porton Bio Competitive Strengths & Weaknesses
Table 53. Lonza Basic Information, Area Served and Competitors
Table 54. Lonza Major Business
Table 55. Lonza Cell Therapy CDMO Services Product and Services
Table 56. Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lonza Recent Developments/Updates
Table 58. Lonza Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Area Served and Competitors
Table 60. Catalent Major Business
Table 61. Catalent Cell Therapy CDMO Services Product and Services
Table 62. Catalent Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. Oxford BioMedica Basic Information, Area Served and Competitors
Table 66. Oxford BioMedica Major Business
Table 67. Oxford BioMedica Cell Therapy CDMO Services Product and Services
Table 68. Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Oxford BioMedica Recent Developments/Updates
Table 70. Oxford BioMedica Competitive Strengths & Weaknesses
Table 71. and meta organisms Basic Information, Area Served and Competitors
Table 72. and meta organisms Major Business
Table 73. and meta organisms Cell Therapy CDMO Services Product and Services
Table 74. and meta organisms Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. and meta organisms Recent Developments/Updates
Table 76. and meta organisms Competitive Strengths & Weaknesses
Table 77. GenScript Basic Information, Area Served and Competitors
Table 78. GenScript Major Business
Table 79. GenScript Cell Therapy CDMO Services Product and Services
Table 80. GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. GenScript Recent Developments/Updates
Table 82. Huakan Biology Basic Information, Area Served and Competitors
Table 83. Huakan Biology Major Business
Table 84. Huakan Biology Cell Therapy CDMO Services Product and Services
Table 85. Huakan Biology Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Cell Therapy CDMO Services Upstream (Raw Materials)
Table 87. Cell Therapy CDMO Services Typical Customers
Table 1. World Cell Therapy CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Therapy CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Therapy CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Therapy CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Therapy CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy CDMO Services Players in 2022
Table 12. World Cell Therapy CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Therapy CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy CDMO Services Player
Table 15. Cell Therapy CDMO Services Market: Company Product Type Footprint
Table 16. Cell Therapy CDMO Services Market: Company Product Application Footprint
Table 17. Cell Therapy CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Therapy CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Cell Therapy CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Therapy CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Therapy CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy CDMO Services Revenue Market Share (2018-2023)
Table 29. World Cell Therapy CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Therapy CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Therapy CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Therapy CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Therapy CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Therapy CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Shanghai Medicilon Biopharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 36. Shanghai Medicilon Biopharmaceutical Co., Ltd. Major Business
Table 37. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product and Services
Table 38. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 40. Shanghai Medicilon Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 41. Puxin Biomedicine Basic Information, Area Served and Competitors
Table 42. Puxin Biomedicine Major Business
Table 43. Puxin Biomedicine Cell Therapy CDMO Services Product and Services
Table 44. Puxin Biomedicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Puxin Biomedicine Recent Developments/Updates
Table 46. Puxin Biomedicine Competitive Strengths & Weaknesses
Table 47. Porton Bio Basic Information, Area Served and Competitors
Table 48. Porton Bio Major Business
Table 49. Porton Bio Cell Therapy CDMO Services Product and Services
Table 50. Porton Bio Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Porton Bio Recent Developments/Updates
Table 52. Porton Bio Competitive Strengths & Weaknesses
Table 53. Lonza Basic Information, Area Served and Competitors
Table 54. Lonza Major Business
Table 55. Lonza Cell Therapy CDMO Services Product and Services
Table 56. Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lonza Recent Developments/Updates
Table 58. Lonza Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Area Served and Competitors
Table 60. Catalent Major Business
Table 61. Catalent Cell Therapy CDMO Services Product and Services
Table 62. Catalent Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. Oxford BioMedica Basic Information, Area Served and Competitors
Table 66. Oxford BioMedica Major Business
Table 67. Oxford BioMedica Cell Therapy CDMO Services Product and Services
Table 68. Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Oxford BioMedica Recent Developments/Updates
Table 70. Oxford BioMedica Competitive Strengths & Weaknesses
Table 71. and meta organisms Basic Information, Area Served and Competitors
Table 72. and meta organisms Major Business
Table 73. and meta organisms Cell Therapy CDMO Services Product and Services
Table 74. and meta organisms Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. and meta organisms Recent Developments/Updates
Table 76. and meta organisms Competitive Strengths & Weaknesses
Table 77. GenScript Basic Information, Area Served and Competitors
Table 78. GenScript Major Business
Table 79. GenScript Cell Therapy CDMO Services Product and Services
Table 80. GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. GenScript Recent Developments/Updates
Table 82. Huakan Biology Basic Information, Area Served and Competitors
Table 83. Huakan Biology Major Business
Table 84. Huakan Biology Cell Therapy CDMO Services Product and Services
Table 85. Huakan Biology Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Cell Therapy CDMO Services Upstream (Raw Materials)
Table 87. Cell Therapy CDMO Services Typical Customers
LIST OF FIGURES
Figure 1. Cell Therapy CDMO Services Picture
Figure 2. World Cell Therapy CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Therapy CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Therapy CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Cell Therapy CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Therapy CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CDMO Services Markets in 2022
Figure 27. United States VS China: Cell Therapy CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Therapy CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Therapy CDMO Services Market Size Market Share by Type in 2022
Figure 31. Cell Therapy CDMO
Figure 32. Cell Therapy CRO
Figure 33. World Cell Therapy CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Cell Therapy CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cell Therapy CDMO Services Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Research Institute
Figure 38. Cell Therapy CDMO Services Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Cell Therapy CDMO Services Picture
Figure 2. World Cell Therapy CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Therapy CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Therapy CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Therapy CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Cell Therapy CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Therapy CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Therapy CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CDMO Services Markets in 2022
Figure 27. United States VS China: Cell Therapy CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Therapy CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Therapy CDMO Services Market Size Market Share by Type in 2022
Figure 31. Cell Therapy CDMO
Figure 32. Cell Therapy CRO
Figure 33. World Cell Therapy CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Cell Therapy CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cell Therapy CDMO Services Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Research Institute
Figure 38. Cell Therapy CDMO Services Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
